RxDoctor Payments Data

Jeffrey Johnson, PA

Physician Assistant · Eagle, IDNPI 1609887801

Payments from drug & device makers

$2,223in general payments, 2019–2025

Across 117 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$300
  • AbbVie$256
  • Takeda Pharmaceuticals U.S.A., Inc.$250
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$241
  • Johnson & Johnson$201
  • Lundbeck LLC$188
  • plus $788 from 15 others

What the payments were for

  • Food & beverage$2,223100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,223 in reported general payments places this provider in the 80th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$4,797
Medicare patients
16
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole31$77,728
VraylarCariprazine Hcl36$50,926
CaplytaLumateperone Tosylate12$18,663
TrintellixVortioxetine Hydrobromide16$12,118
BelsomraSuvorexant18$11,342
VyvanseLisdexamfetamine Dimesylate11$4,295
Lurasidone Hcl22$3,530
Aripiprazole65$2,624
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine30$1,748
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine32$1,105
Lamotrigine64$1,035
Bupropion XlBupropion Hcl47$809
Duloxetine Hcl32$668
Quetiapine Fumarate19$541
Clonazepam64$536

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$300$77,72831 claims
AbbVieVraylar$256$50,92636 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$241$18,66312 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$250$16,41327 claims
MerckBelsomra$32$11,34218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Eagle

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →